Abhilasha Singh: Lp(a) as a Long-Term Cardiovascular Risk Signal in Healthy Women
Abhilasha Singh, Review Editor at Frontiers in Stroke and Reviewer at Springer Nature Phytomedicine, shared on LinkedIn about a recent article by Ask Tybjærg Nordestgaard and et al, published in JAMA Cardiology:
“Lp(a): A 30-Year Cardiovascular Risk Signal We May Be Underestimating
A 30-year follow-up of ~27,000 initially healthy women (JAMA Cardiology, 2026) shows that elevated Lipoprotein(a) [Lp(a)] independently predicts long-term cardiovascular risk.
What the Data Show
- Lp(a) level of 30 mg/dL or higher is associated with an increased incidence of major adverse cardiovascular events.
- Lp(a) levels of 120 mg/dL or higher increase the risk of coronary heart disease, ischemic stroke, and cardiovascular death.
- Clear dose–response gradient
- Risk persists beyond traditional factors
- Lp(a) is largely genetically determined
Why This Matters Clinically
- Prevention remains centered on LDL-C
- Most 10-year risk models do not integrate Lp(a)
- ‘Normal cholesterol’ does not equal absence of inherited risk.
- Short-term prediction may miss lifelong exposure
Perspective
This study invites reconsideration of how we define and operationalize cardiovascular risk in the era of genomic medicine. ”
Title: Thirty-Year Risk of Cardiovascular Disease Among Healthy Women According to Clinical Thresholds of Lipoprotein(a)
Authors: Tybjærg Nordestgaard, Daniel I. Chasman, Vinayaga Moorthy, Jordan M. Kraaijenhof, Nancy R. Cook, I-Min Lee, Julie E. Buring, Paul M. Ridker
Read the Full Article on JAMA Cardiology .
Stay updated on all scientific advances with Hemostasis Today .
-
Apr 22, 2026, 07:56Shruti Kharat: Closing the Gap in Early Detection of Factor VIII Inhibitors
-
Apr 22, 2026, 07:46Gregory Piazza: Ushering in a New Era in PE Therapy and Improved Clinical Outcomes for Our Patients
-
Apr 22, 2026, 07:40Akshat Jain: WIL33 Study Advances Factor Prophylaxis in Children with von Willebrand Disease
-
Apr 22, 2026, 07:36Selma Turkovic: Blood Transfusion Education and Discussion Group Webinar 61
-
Apr 22, 2026, 07:34Aikati Anastasiou: Advancing Stroke Imaging Insights from the DISTAL Trial
-
Apr 22, 2026, 07:26Maxime Dely: How Do We Balance Benefit and Risk in Chronic Hematologic Diseases?
-
Apr 22, 2026, 07:19Sarah Richardson: Bringing Insights from HFA Symposium Back to Real Life
-
Apr 22, 2026, 07:17Karuna Kumar: Interesting Trial from Gambia on Treating Iron Deficiency in Children
-
Apr 22, 2026, 07:12Mary Catherine Moffett: Celebrating 32 Years of Patient-Centered Advocacy with the Hemophilia Federation of America